Chiang Mai Ram Medical Business Public Co. Ltd.(TH:CMR)
฿1.250.00 (0.00%)
TH:CMR
Chiang Mai Ram Medical Business Public Co. Ltd. financials statements
฿1.25
At close:0.00 (0.00%)
Chiang Mai Ram Medical Business Public Co. Ltd. (CMR) Ratios
Chiang Mai Ram Medical Business Public Co. Ltd. Ratios
TH:CMR's free cash flow for Q2 2026 was ฿14.13M. For the 2026 fiscal year, TH:CMR's free cash flow was decreased by ฿-19.83M and operating cash flow was ฿33.96M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.35 | 0.33 | 0.35 | 0.37 | 0.41 |
| Quick Ratio | 0.33 | 0.29 | 0.31 | 0.34 | 0.38 |
| Cash Ratio | 0.18 | 0.08 | 0.09 | 0.07 | 0.13 |
| Solvency Ratio | 0.80 | 0.12 | 0.13 | 0.16 | 0.10 |
| Operating Cash Flow Ratio | 0.24 | 0.29 | 0.32 | 0.34 | 0.20 |
| Short-Term Operating Cash Flow Coverage | 0.47 | 0.42 | 0.46 | 0.51 | 0.31 |
| Net Current Asset Value | ฿ -2.68B | ฿ -4.09B | ฿ -4.45B | ฿ -5.03B | ฿ -5.08B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.32 | 0.30 | 0.28 | 0.34 |
| Debt-to-Equity Ratio | 0.49 | 0.93 | 0.85 | 0.81 | 1.05 |
| Debt-to-Capital Ratio | 0.33 | 0.48 | 0.46 | 0.45 | 0.51 |
| Long-Term Debt-to-Capital Ratio | 0.16 | 0.26 | 0.26 | 0.27 | 0.35 |
| Financial Leverage Ratio | 1.81 | 2.92 | 2.83 | 2.83 | 3.08 |
| Debt Service Coverage Ratio | 0.32 | 0.37 | 0.44 | 0.55 | 0.37 |
| Interest Coverage Ratio | 0.92 | 3.17 | 4.17 | 7.56 | 6.14 |
| Debt to Market Cap | 0.38 | 0.49 | 0.46 | 0.37 | 0.35 |
| Interest Debt Per Share | 0.57 | 0.90 | 0.96 | 1.03 | 1.11 |
| Net Debt to EBITDA | 3.27 | 3.34 | 3.05 | 2.70 | 4.53 |
| Profitability Margins | |||||
| Gross Profit Margin | 17.34% | 22.40% | 22.74% | 27.13% | 22.36% |
| EBIT Margin | 3.68% | 9.23% | 12.50% | 17.99% | 12.60% |
| EBITDA Margin | 21.40% | 18.28% | 22.30% | 27.01% | 20.86% |
| Operating Profit Margin | 3.68% | 9.16% | 12.20% | 17.31% | 12.60% |
| Pretax Profit Margin | 103.10% | 6.34% | 9.57% | 15.37% | 10.83% |
| Net Profit Margin | 98.00% | 2.47% | 4.30% | 9.68% | 6.97% |
| Continuous Operations Profit Margin | 100.03% | 4.57% | 7.56% | 13.14% | 8.69% |
| Net Income Per EBT | 95.06% | 38.95% | 44.90% | 63.00% | 64.33% |
| EBT Per EBIT | 2801.71% | 69.19% | 78.47% | 88.78% | 85.97% |
| Return on Assets (ROA) | 30.00% | 1.18% | 1.76% | 3.57% | 2.28% |
| Return on Equity (ROE) | 54.36% | 3.46% | 4.98% | 10.11% | 7.02% |
| Return on Capital Employed (ROCE) | 1.64% | 6.21% | 6.72% | 8.32% | 5.45% |
| Return on Invested Capital (ROIC) | 1.29% | 3.50% | 4.28% | 5.61% | 3.72% |
| Return on Tangible Assets | 30.82% | 1.22% | 1.81% | 3.65% | 2.33% |
| Earnings Yield | 42.31% | 1.82% | 2.66% | 4.60% | 2.37% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.46 | 8.49 | 7.81 | 6.29 | 5.89 |
| Payables Turnover | 10.36 | 13.72 | 14.11 | 11.56 | 11.41 |
| Inventory Turnover | 39.01 | 31.72 | 33.14 | 31.95 | 32.22 |
| Fixed Asset Turnover | 0.75 | 0.78 | 0.73 | 0.74 | 0.59 |
| Asset Turnover | 0.31 | 0.48 | 0.41 | 0.37 | 0.33 |
| Working Capital Turnover Ratio | -1.31 | -2.49 | -2.45 | -2.66 | -2.42 |
| Cash Conversion Cycle | 30.61 | 27.93 | 31.91 | 37.88 | 41.27 |
| Days of Sales Outstanding | 56.49 | 43.02 | 46.76 | 58.03 | 61.93 |
| Days of Inventory Outstanding | 9.36 | 11.51 | 11.01 | 11.42 | 11.33 |
| Days of Payables Outstanding | 35.23 | 26.60 | 25.86 | 31.58 | 31.99 |
| Operating Cycle | 65.84 | 54.53 | 57.77 | 69.46 | 73.26 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.15 | 0.23 | 0.25 | 0.28 | 0.16 |
| Free Cash Flow Per Share | 0.00 | 0.15 | 0.15 | 0.19 | -0.06 |
| Dividend Paid and CapEx Coverage Ratio | 0.34 | 1.52 | 1.37 | 1.64 | 0.55 |
| Capital Expenditure Coverage Ratio | 1.02 | 3.12 | 2.62 | 3.03 | 0.72 |
| Operating Cash Flow Coverage Ratio | 0.28 | 0.26 | 0.27 | 0.28 | 0.15 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.17 | 0.20 | 0.22 | 0.15 |
| Free Cash Flow Yield | 0.24% | 8.72% | 7.67% | 6.86% | -1.97% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 2.37 | 54.83 | 37.55 | 20.92 | 42.15 |
| Price-to-Sales (P/S) Ratio | 2.32 | 1.36 | 1.61 | 2.10 | 2.94 |
| Price-to-Book (P/B) Ratio | 1.28 | 1.90 | 1.87 | 2.20 | 2.96 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 424.71 | 11.47 | 13.04 | 14.58 | -50.74 |
| Price-to-Operating Cash Flow Ratio | 9.34 | 7.77 | 8.05 | 9.77 | 19.30 |
| Price-to-Earnings Growth (PEG) Ratio | 0.00 | -1.36 | -0.64 | 0.26 | 0.89 |
| Enterprise Value Multiple | 14.10 | 10.76 | 10.29 | 10.48 | 18.60 |
| Enterprise Value | 7.53B | 10.40B | 11.62B | 14.74B | 16.27B |
| EV to EBITDA | 14.10 | 10.76 | 10.29 | 10.48 | 18.60 |
| EV to Sales | 3.02 | 1.97 | 2.29 | 2.83 | 3.88 |
| EV to Free Cash Flow | 553.15 | 16.65 | 18.53 | 19.63 | -67.07 |
| EV to Operating Cash Flow | 12.16 | 11.28 | 11.45 | 13.16 | 25.52 |
| Tangible Book Value Per Share | 1.07 | 1.37 | 1.61 | 1.88 | 1.53 |
| Shareholders’ Equity Per Share | 1.11 | 0.93 | 1.08 | 1.24 | 1.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.03 | 0.28 | 0.21 | 0.19 | 0.17 |
| Revenue Per Share | 0.61 | 1.30 | 1.25 | 1.29 | 1.04 |
| Net Income Per Share | 0.60 | 0.03 | 0.05 | 0.13 | 0.07 |
| Tax Burden | 0.95 | 0.39 | 0.45 | 0.63 | 0.64 |
| Interest Burden | 28.02 | 0.69 | 0.77 | 0.85 | 0.86 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.14 | 0.16 | 0.14 | 0.13 | 0.13 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.25 | 2.75 | 4.66 | 1.40 | 1.40 |
Currency in THB
